| Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants MJ Lindberg, R Byström, N Boknäs, PM Andersen, M Oliveberg Proceedings of the National Academy of Sciences 102 (28), 9754-9759, 2005 | 283 | 2005 |
| Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII L Faxälv, N Boknäs, JO Ström, P Tengvall, E Theodorsson, S Ramström, ... Blood, The Journal of the American Society of Hematology 122 (23), 3818-3824, 2013 | 76 | 2013 |
| Platelet function testing at low platelet counts: When can you trust your analysis? N Boknäs, AS Macwan, AL Södergren, S Ramström Research and practice in thrombosis and haemostasis 3 (2), 285-290, 2019 | 30 | 2019 |
| Thrombin-induced platelet activation via PAR4: pivotal role for exosite II N Boknäs, L Faxälv, DS Centellas, M Wallstedt, S Ramström, ... Thrombosis and haemostasis 112 (09), 558-565, 2014 | 25 | 2014 |
| Varying effects of tyrosine kinase inhibitors on platelet function—A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications? S Deb, N Boknäs, C Sjöström, A Tharmakulanathan, K Lotfi, S Ramström Cancer medicine 9 (1), 313-323, 2020 | 22 | 2020 |
| Contact activation: important to consider when measuring the contribution of tissue factor‐bearing microparticles to thrombin generation using phospholipid‐containing reagents N Boknäs, L Faxälv, TL Lindahl, S Ramström Journal of Thrombosis and Haemostasis 12 (4), 515-518, 2014 | 21 | 2014 |
| Associations between hemostatic markers and mortality in COVID-19–Compounding effects of D-dimer, antithrombin and PAP complex N Boknäs, C Laine, A Hillarp, AS Macwan, KM Gustafsson, TL Lindahl, ... Thrombosis Research 213, 97-104, 2022 | 19 | 2022 |
| Flow cytometry-based platelet function testing is predictive of symptom burden in a cohort of bleeders N Boknäs, S Ramström, L Faxälv, TL Lindahl Platelets 29 (5), 512-519, 2018 | 16 | 2018 |
| Tissue factor-negative cell-derived microparticles play a distinctive role in hemostasis: a viewpoint review LL Horstman, RF McCauley, W Jy, YS Ahn Seminars in thrombosis and hemostasis 45 (05), 509-513, 2019 | 13 | 2019 |
| Caveats in studies of the physiological role of polyphosphates in coagulation TL Lindahl, S Ramström, N Boknäs, L Faxälv Biochemical Society Transactions 44 (1), 35-39, 2016 | 13 | 2016 |
| Quantification of platelet contractile movements during thrombus formation K Tunströmer, L Faxälv, N Boknäs, TL Lindahl Thrombosis and Haemostasis 118 (09), 1600-1611, 2018 | 12 | 2018 |
| Gradient-dependent inhibition of stimulatory signaling from platelet G protein-coupled receptors AS Macwan, N Boknäs, MP Ntzouni, S Ramström, JM Gibbins, L Faxälv, ... haematologica 104 (7), 1482, 2019 | 10 | 2019 |
| Effects of heparin and bivalirudin on thrombin-induced platelet activation: differential modulation of PAR signaling drives divergent prothrombotic responses M Lund, AS Macwan, K Tunströmer, TL Lindahl, N Boknäs Frontiers in Cardiovascular Medicine 8, 717835, 2021 | 7 | 2021 |
| Response: Platelets do not generate activated factor XII—how inappropriate experimental models have led to misleading conclusions N Boknäs, L Faxälv, JO Ström, P Tengvall, E Theodorsson, S Ramström, ... Blood, The Journal of the American Society of Hematology 124 (10), 1692-1694, 2014 | 7 | 2014 |
| Scanning laser-induced endothelial injury: a standardized and reproducible thrombosis model for intravital microscopy P Larsson, V Tarlac, TY Wang, T Bonnard, CE Hagemeyer, JR Hamilton, ... Scientific Reports 12 (1), 3955, 2022 | 4 | 2022 |
| Storage‐induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient N Tynngård, N Boknäs, M Trinks, A Dreimane, G Berlin Transfusion 59 (2), 723-728, 2019 | 4 | 2019 |
| Thrombus remodelling by reversible and irreversible P2Y12 inhibitors K Tunströmer, L Faxälv, P Larsson, TL Lindahl, N Boknäs Platelets 34 (1), 2157805, 2023 | 3 | 2023 |
| Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors-a way to improve personalized cancer therapy? K Lotfi, S Deb, C Sjöström, A Tharmakulanathan, N Boknäs, S Ramström Blood 128 (22), 1908, 2016 | 3 | 2016 |
| PO-55-Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors–a way to improve personalized cancer therapy? S Deb, C Sjöström, A Tharmakulanathan, N Boknäs, K Lotfi, S Ramström Thrombosis Research 140, S196-S197, 2016 | 3 | 2016 |
| Finding and following: a deep learning-based pipeline for tracking platelets during thrombus formation in vivo and ex vivo AS McGovern, P Larsson, V Tarlac, N Setiabakti, L Shabani Mashcool, ... Platelets 35 (1), 2344512, 2024 | 1 | 2024 |
Sofia RamstromAss professor, Dept. of Clinical and Experimental Medicine, Linköping UniversityVerified email at liu.se